Henshaw Capital’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,247
Closed -$218K 288
2023
Q2
$218K Hold
5,247
0.01% 234
2023
Q1
$217K Hold
5,247
0.01% 230
2022
Q4
$216K Hold
5,247
0.01% 221
2022
Q3
$230K Hold
5,247
0.02% 250
2022
Q2
$258K Hold
5,247
0.02% 249
2022
Q1
$298K Sell
5,247
-273
-5% -$14.5K 0.02% 249
2021
Q4
$290K Hold
5,520
0.02% 272
2021
Q3
$330K Hold
5,520
0.02% 235
2021
Q2
$374K Hold
5,520
0.02% 224
2021
Q1
$362K Hold
5,520
0.02% 223
2020
Q4
$311K Buy
5,520
+809
+17% +$39.8K 0.02% 250
2020
Q3
$229K Hold
4,711
0.02% 280
2020
Q2
$262K Hold
4,711
0.02% 242
2020
Q1
$239K Buy
4,711
+1,370
+41% +$91.9K 0.02% 224
2019
Q4
$258K Buy
+3,341
New +$236K 0.02% 224

Other funds holding NUVA

Henshaw Capital's NUVA Position: Q3 2023 in Review

Henshaw Capital sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 5,247 shares — an estimated $218K sold.

Henshaw Capital first reported a position in NUVA in Q4 2019 and held it in 15 quarters. The position peaked at $374K in Q2 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Henshaw Capital reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Henshaw Capital sold 5,247 NuVasive, Inc. shares in Q3 2023, an estimated $218K.
  • Henshaw Capital first reported a position in NuVasive, Inc. in Q4 2019 and held it in 15 quarters.
  • Henshaw Capital's NuVasive, Inc. position peaked at $374K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Henshaw Capital's 13F filing for Q3 2023, filed 28 May 2026.